|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
27.050 +0.200 (+0.745%) Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| ROAA (%) | 1.389% | 7.089% | 7.877% | 13.315% | 12.937% |
| ROAE (%) | 1.943% | 9.961% | 10.663% | 16.769% | 17.169% |
| Return on Capital Employed (%) | 1.620% | 7.928% | 8.501% | 13.499% | 9.535% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Gross Profit Margin (%) | -- | -- | 39.312% | 43.121% | 47.093% |
| EBITDA Margin (%) | 15.679% | 35.401% | 38.032% | 69.776% | 72.384% |
| Pre-tax Profit Margin (%) | 10.063% | 33.702% | 36.623% | 70.768% | 69.551% |
| Net Profit Margin (%) | 6.136% | 27.422% | 28.454% | 55.224% | 54.861% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Current Ratio (X) | 1.720 X | 2.741 X | 2.978 X | 4.497 X | 10.220 X |
| Quick Ratio (X) | 1.712 X | 2.735 X | 2.972 X | 4.494 X | 10.216 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Total Liabilities / Total Assets(%) | 16.067% | 17.611% | 17.363% | 13.209% | 8.447% |
| Total Debt / Total Assets (%) | 9.883% | 11.275% | 9.909% | 4.101% | 1.699% |
| Net Debt / Total Assets (%) | 2.714% | -13.724% | -18.447% | -31.189% | -49.362% |
| Total Debt / Shareholders' Funds (%) | 13.708% | 15.916% | 13.855% | 5.354% | 2.051% |
| Long Term Debt / Shareholders' Funds (%) | 3.498% | 4.077% | 3.738% | 2.237% | 1.727% |
| Net Debt / Shareholders' Funds (%) | 3.765% | -19.372% | -25.795% | -40.718% | -59.606% |
| Net Cash / (Debt) ($) | (778.169M) | 4.073B | 5.063B | 7.405B | 9.629B |
| Net Cash / (Debt) per share ($) | (0.903) | 4.669 | 5.804 | 8.487 | 11.036 |
| Total Debt / Capital Employed (%) | 11.330% | 13.102% | 11.467% | 4.565% | 1.804% |
| Interest Coverage Ratio (X) | 5.705 X | 21.756 X | 32.197 X | 149.113 X | 44.726 X |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Inventory Turnover (Day) | -- | -- | 1.201 Day | 0.666 Day | 0.640 Day |
| Receivables Turnover (Day) | 72.597 Day | 56.715 Day | 47.647 Day | 45.917 Day | 51.677 Day |
| Payables Turnover (Day) | 14.002 Day | 10.066 Day | 7.877 Day | 8.722 Day | 10.090 Day |
| Remarks: | Real time quote last updated: 08/05/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 405,143 |
| %Change | -79.991% |
| EPS / (LPS) | RMB 0.470 |
| NBV Per Share (¥) | RMB 24.000 |